Five-year outcomes of a Schlemm’s canal microstent (Hydrus Microstent) with cataract surgery in open angle glaucoma: real-world results
This study provides the longest follow-up data on Hydrus+CS, confirming its safety and efficacy in mild to severe OAG.
Authors
- Paul Harasymowycz (ORCID: https://orcid.org/0000-0003-2524-7811)
- Ali Salimi (ORCID: https://orcid.org/0000-0003-0016-3478)
- Basma Matar
Institutions
- McGill University (CA)
Publication Details
- Journal
- Canadian Journal of Ophthalmology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.1016/j.jcjo.2025.09.009
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00